In early 2017, a federal Judge blocked a Centers for Medicare & Medicaid Services (CMS) interim final rule regarding premium assistance for end-stage renal disease (ESRD) patients. CMS did not technically bar ESRD patients from getting help with premiums. The agency was simply concerned with the inappropriate shifting of this vulnerable population from traditional Part A and Part B to Patient Protection and Affordable Care Act (PPACA) exchanges, therefore raising costs for these participating health plans.
Many dialysis center organizations nationwide have formed foundations to pay these premiums or funnel the premium payments directly to the health plans for patients who are on dialysis and cannot afford the high premiums. Typically, PPACA health plans pay ESRD providers about $200,000 per year to treat one ESRD patient, while traditional Medicare pays these providers between $50,000 and $100,000 per year. Premiums run about $4,000 to $5,000 per year, per patient. Therefore, the financial gain is significant.
CMS received comments from social workers resulting from its request for information (RFI) placed in the Federal Register last Aug. 23, 2016; the commenters noted that once ESRD beneficiaries received a kidney transplant, the dialysis centers stopped paying their premiums. Patients then have to scramble to secure replacement aftercare coverage.
The court stated that CMS did not address what happens to family members, since Medicare will only cover the ESRD patient. The court also noted that CMS did not offer an adequate notice and comment period. CMS will likely address these issues and reissue the rule in the next round.
What are the issues and problems determined by CMS regarding this premium assistance controversy? First, there are new disclosure requirements in the proposed rule promoting transparency and forcing dialysis facilities to disclose to patients and insurers details about the premium assistance programs. Second, there is a new pre-enrollment verification process for special enrollment periods that CMS believes has been abused by patients in the past, with the assistance of the ESRD providers. Third, there has been market instability related to high-cost individuals affecting the risk pool, according to CMS. The higher claim costs associated with sicker ESRD beneficiaries has resulted in higher premiums in the PPACA marketplace as well.
Insurers are not allowed to sell insurance to individuals already enrolled in Medicare A and B or Medicaid, in accordance with section 1882 (d)(3)(i)(ii) of the Social Security Statute. Such an illegal act is punishable by up to five years imprisonment and civil monetary penalties. In August 2016, the CMS Center for Program Integrity sent a letter to all Medicare-enrolled dialysis facilities placing them on notice concerning this inappropriate practice of steering ESRD beneficiaries from traditional Medicare to the PPACA marketplace. CMS has stated that 90 percent of ESRD facilities have been making third-party payments, and the number of ESRD enrollees in marketplace plans doubled from 2014 to 2015.
A significant problem is that transplant queues could be delayed since ESRD patients may not be able to demonstrate continuing coverage after they stop dialysis treatments and premium payments cease. The end result is that such patients lose their PPACA coverage. RFI comments received by CMS highlight that social workers have been compensated by dialysis facilities for steering patients to the marketplace and have been retaliated against for failing to cooperate in this endeavor. Another major problem is that Part B premiums go up 10 percent per year for delayed enrollment in Part B. A three-year delay could amount to about a $40-per-month premium increase for the rest of a beneficiary’s life. This is significant for low-income ESRD individuals. Finally, individuals steered to an PPACA plan who then have a kidney transplant and later enroll in Medicare Part B will find that their immunosuppressant drugs will not be covered. This would be catastrophic for any ESRD beneficiary.
What are the conclusions that CMS has drawn from this controversy, applicable to premium assistance? CMS is actually considering an absolute prohibition if disclosure proves inadequate to stop perceived abuses. The Medicare program is working with the federal and state law enforcement to investigate potential fraud and abuse in this premium assistance area. CMS will attempt to issue civil monetary penalties to dialysis providers when their actions result in late enrollment penalties for ESRD beneficiaries.
Finally, CMS is concerned with interference with transplant readiness. ESRD patients with PPACA market coverage have struggled to demonstrate continuity of coverage since their third-party premium assistance ends when they no longer need dialysis treatment. This continuity is required for transplant readiness. CMS is concerned about additional financial exposure. Out-of-pocket costs likely are higher for dually eligible beneficiaries who could be enrolled in Medicare and Medicaid but are steered to the PPACA plans. CMS is concerned with mid-year coverage disruptions as well.
The current lack of transparency in these payment arrangements translates to patients having their coverage disrupted at any time if their plan discovers and rejects third-party premium payments. ESRD patients need to examine all ramifications associated with rejecting traditional Medicare and utilizing the PPACA marketplace plans.
In the last six weeks, my colleagues and I have dealt with two situations in which clinics either missed or did not receive the orange
Well, the fate of the Patient Protection and Affordable Care Act’s (PPACA’s) enhanced premium tax credits, or PTCs, still hangs in the balance. And like
Please log in to your account to comment on this article.
Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.
Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY26 IPPS, including new ICD-10-CM/PCS codes, CCs/MCCs, and MS-DRGs, plus insights, analysis and answers to your questions from two of the country’s most respected subject matter experts.
Stay ahead of the 2026-2027 audit surge with “Top 10 Audit Targets for 2026-2027 for Hospitals & Physicians: Protect Your Revenue,” a high-impact webcast led by Michael Calahan, PA, MBA. This concise session gives hospitals and physicians clear insight into the most likely federal audit targets, such as E/M services, split/shared and critical care, observation and admissions, device credits, and Two-Midnight Rule changes, and shows how to tighten documentation, coding, and internal processes to reduce denials, recoupments, and penalties. Attendees walk away with practical best practices to protect revenue, strengthen compliance, and better prepare their teams for inevitable audits.
As AI reshapes healthcare compliance, the risk of biased outputs and opaque decision-making grows. This webcast, led by Frank Cohen, delivers a practical Four-Pillar Governance Framework—Transparency, Accountability, Fairness, and Explainability—to help you govern AI-driven claim auditing with confidence. Learn how to identify and mitigate bias, implement robust human oversight, and document defensible AI review processes that regulators and auditors will accept. Discover concrete remedies, from rotation protocols to uncertainty scoring, and actionable steps to evaluate vendors before contracts are signed. In a regulatory landscape that moves faster than ever, gain the tools to stay compliant, defend your processes, and reduce liability while maintaining operational effectiveness.
Get clear, practical answers to Medicare’s most confusing regulations. Join Dr. Ronald Hirsch as he breaks down real-world compliance challenges and shares guidance your team can apply right away.
Federal auditors are zeroing in on Inpatient Rehabilitation Facility (IRF) and hospital rehab unit services, with OIG and CERT audits leading to millions in penalties—often due to documentation and administrative errors, not quality of care. Join compliance expert Michael Calahan, PA, MBA, to learn the five clinical “pillars” of IRF-PPS admissions, key documentation requirements, and real-life case lessons to help protect your revenue.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
